中国卫生产业
中國衛生產業
중국위생산업
CHINA HEALTH INDUSTRY
2015年
11期
181-183
,共3页
慢性阻塞性肺疾病%肺功能%患病率
慢性阻塞性肺疾病%肺功能%患病率
만성조새성폐질병%폐공능%환병솔
Chronic obstructive pulmonary disease%Pulmonary function%Prevalence rate
目的:探讨一汽厂区慢性阻塞性肺疾病(COPD)患病及诊断情况。方法对一汽厂区年龄在45~70岁自愿接受调查的常住居民进行调查,问卷内容包括既往有无诊断COPD及其它疾病情况,呼吸道症状,吸烟史、是否戒烟、吸烟量、吸烟时间、是否有被动吸烟、职业、收入情况等。使用COPD6型肺功能仪进行通气功能测定(测定第1秒用力呼气容积FEV1,及6秒用力呼气容积FEV6)。COPD的诊断标准为:吸入沙丁胺醇2喷(200μg)后FEV1/FEV6<70%者,诊断为COPD。结果对1300例受试者进行筛选,符合纳入标准者1270例,完成合格问卷及肺功能的1261例,平均年龄(58.0±9.1)岁。男382例,平均年龄(59.8±9.0)岁;女879例,平均年龄(57.1±9.0)岁。通过肺功能诊断COPD者77例,年龄(62.4±9.8)岁,总患病率为6.1%。其中男39例,患病率为10.2%;女38例,患病率为4.3%。年龄40~49岁8例(10.4%);50~59岁17例(22.0%);60~69岁3l例(40.3%);70~75岁21例(27.3%)。体重指数(BMI)<18.5 kg/m2者3例(3.9%);18.5~23.9 kg/m2者29例(37.7%);24~27.9 kg/m2者34例(44.2%);≥28 kg/m2者273例(21.6%)。现在吸烟者19例(24.7%);已戒烟者17例(22.1%);被动吸烟者16例(20.8%);不吸烟者(包括被动吸烟者)41例(53.4%)。其中仅19例既往被诊为COPD,诊断率24.68%。无呼吸道症状者38例(49.35%)。诊断为COPD的受试者中,GOLD分级I级23例(36.36%),Ⅱ级ll例(40.26%),Ⅲ级15例(19.48%),Ⅳ级3例(3.90%)。该调查发现,通过肺功能诊断为COPD受试者中有49.4%(38/77)无咳嗽、咳痰、呼吸困难等呼吸系统症状。 GOLD分级I级受试者显著多于Ⅱ级、Ⅲ级、Ⅳ级受试者(P=0.0002)。不同GOLD分级的COPD诊断率:I级l例(1/28,3.57%);Ⅱ级7例(7/33,21.21%);Ⅲ级9例(9/15,60.00%);Ⅳ级2例(2/3,66.67%)。GOLD分级I级COPD诊断率要明显低于Ⅱ级、Ⅲ级、Ⅳ级(P=0.042)。无症状患者与GOLD分级:I级23例(23/28,82.14%);Ⅱ级11例(11/33,33.33%);Ⅲ级3例(9/15,20.00%)。结论目前一汽厂区居民COPD患病率较高,但诊断率很低,说明一汽厂区社区的COPD防治措施有待进一步改进和完善。
目的:探討一汽廠區慢性阻塞性肺疾病(COPD)患病及診斷情況。方法對一汽廠區年齡在45~70歲自願接受調查的常住居民進行調查,問捲內容包括既往有無診斷COPD及其它疾病情況,呼吸道癥狀,吸煙史、是否戒煙、吸煙量、吸煙時間、是否有被動吸煙、職業、收入情況等。使用COPD6型肺功能儀進行通氣功能測定(測定第1秒用力呼氣容積FEV1,及6秒用力呼氣容積FEV6)。COPD的診斷標準為:吸入沙丁胺醇2噴(200μg)後FEV1/FEV6<70%者,診斷為COPD。結果對1300例受試者進行篩選,符閤納入標準者1270例,完成閤格問捲及肺功能的1261例,平均年齡(58.0±9.1)歲。男382例,平均年齡(59.8±9.0)歲;女879例,平均年齡(57.1±9.0)歲。通過肺功能診斷COPD者77例,年齡(62.4±9.8)歲,總患病率為6.1%。其中男39例,患病率為10.2%;女38例,患病率為4.3%。年齡40~49歲8例(10.4%);50~59歲17例(22.0%);60~69歲3l例(40.3%);70~75歲21例(27.3%)。體重指數(BMI)<18.5 kg/m2者3例(3.9%);18.5~23.9 kg/m2者29例(37.7%);24~27.9 kg/m2者34例(44.2%);≥28 kg/m2者273例(21.6%)。現在吸煙者19例(24.7%);已戒煙者17例(22.1%);被動吸煙者16例(20.8%);不吸煙者(包括被動吸煙者)41例(53.4%)。其中僅19例既往被診為COPD,診斷率24.68%。無呼吸道癥狀者38例(49.35%)。診斷為COPD的受試者中,GOLD分級I級23例(36.36%),Ⅱ級ll例(40.26%),Ⅲ級15例(19.48%),Ⅳ級3例(3.90%)。該調查髮現,通過肺功能診斷為COPD受試者中有49.4%(38/77)無咳嗽、咳痰、呼吸睏難等呼吸繫統癥狀。 GOLD分級I級受試者顯著多于Ⅱ級、Ⅲ級、Ⅳ級受試者(P=0.0002)。不同GOLD分級的COPD診斷率:I級l例(1/28,3.57%);Ⅱ級7例(7/33,21.21%);Ⅲ級9例(9/15,60.00%);Ⅳ級2例(2/3,66.67%)。GOLD分級I級COPD診斷率要明顯低于Ⅱ級、Ⅲ級、Ⅳ級(P=0.042)。無癥狀患者與GOLD分級:I級23例(23/28,82.14%);Ⅱ級11例(11/33,33.33%);Ⅲ級3例(9/15,20.00%)。結論目前一汽廠區居民COPD患病率較高,但診斷率很低,說明一汽廠區社區的COPD防治措施有待進一步改進和完善。
목적:탐토일기엄구만성조새성폐질병(COPD)환병급진단정황。방법대일기엄구년령재45~70세자원접수조사적상주거민진행조사,문권내용포괄기왕유무진단COPD급기타질병정황,호흡도증상,흡연사、시부계연、흡연량、흡연시간、시부유피동흡연、직업、수입정황등。사용COPD6형폐공능의진행통기공능측정(측정제1초용력호기용적FEV1,급6초용력호기용적FEV6)。COPD적진단표준위:흡입사정알순2분(200μg)후FEV1/FEV6<70%자,진단위COPD。결과대1300례수시자진행사선,부합납입표준자1270례,완성합격문권급폐공능적1261례,평균년령(58.0±9.1)세。남382례,평균년령(59.8±9.0)세;녀879례,평균년령(57.1±9.0)세。통과폐공능진단COPD자77례,년령(62.4±9.8)세,총환병솔위6.1%。기중남39례,환병솔위10.2%;녀38례,환병솔위4.3%。년령40~49세8례(10.4%);50~59세17례(22.0%);60~69세3l례(40.3%);70~75세21례(27.3%)。체중지수(BMI)<18.5 kg/m2자3례(3.9%);18.5~23.9 kg/m2자29례(37.7%);24~27.9 kg/m2자34례(44.2%);≥28 kg/m2자273례(21.6%)。현재흡연자19례(24.7%);이계연자17례(22.1%);피동흡연자16례(20.8%);불흡연자(포괄피동흡연자)41례(53.4%)。기중부19례기왕피진위COPD,진단솔24.68%。무호흡도증상자38례(49.35%)。진단위COPD적수시자중,GOLD분급I급23례(36.36%),Ⅱ급ll례(40.26%),Ⅲ급15례(19.48%),Ⅳ급3례(3.90%)。해조사발현,통과폐공능진단위COPD수시자중유49.4%(38/77)무해수、해담、호흡곤난등호흡계통증상。 GOLD분급I급수시자현저다우Ⅱ급、Ⅲ급、Ⅳ급수시자(P=0.0002)。불동GOLD분급적COPD진단솔:I급l례(1/28,3.57%);Ⅱ급7례(7/33,21.21%);Ⅲ급9례(9/15,60.00%);Ⅳ급2례(2/3,66.67%)。GOLD분급I급COPD진단솔요명현저우Ⅱ급、Ⅲ급、Ⅳ급(P=0.042)。무증상환자여GOLD분급:I급23례(23/28,82.14%);Ⅱ급11례(11/33,33.33%);Ⅲ급3례(9/15,20.00%)。결론목전일기엄구거민COPD환병솔교고,단진단솔흔저,설명일기엄구사구적COPD방치조시유대진일보개진화완선。
Objective To investigate the FAW chronic obstructive pulmonary disease (COPD) prevalence and diagnosis.Methods The method of FAW at the age of 45~70 voluntary survey residents conducted a survey, the questionnaire included with or without previousdiagnosis of COPD and other diseases, respiratory symptoms, smoking history, smoking,smoking, smoking time, whether passive smoking, occupation, income etc.Pulmonary function was measured using COPD6 type pulmonary function (FEV1 FEV1 determination,and forced expiratory volume FEV6 6 seconds). The diagnostic criteria for COPD: 2 sprayinhalation of salbutamol (200 micrograms) of FEV1/FEV6<70%, diagnosed as COPD.Results A total of 1 300 subjects were screened, 1 270 patients meet the inclusion criteria,1 261 cases of eligible questionnaires and lung function, mean age (58.0±9.1) years old. 382 cases were male, mean age (59.8±9.0) years; 879 were female, mean age (57.1±9.0) years old. Through the 77 cases of pulmonary function in the diagnosis of COPD, age(62.4±9.8)years, the total prevalence rate was 6.1%. Of which 39 cases were male, the prevalence rate was 10.2%; 38 cases were female, the prevalence rate is 4.3%. The age of 40 in a 49 year old in 8 cases (10.4%);50 ~59 years old in 17 cases (22.0%);60~69 3L cases(40.3%); 70~75 years old in 21 cases (27.3%). Body mass index (BMI) of 3 cases of<18.5 kg/m2 (3.9%);29 cases of 18.5~23.9 kg/m2 (37.7%);34 cases of 24~27.9 kg/m2(44.2%);more than 273 cases of 28 kg/m2 (21.6%). Current smokers in 19 cases(24.7%);17 cases had quit smoking (22.1%);16 cases (20.8%);passive smokersnonsmok-ers (including passive smokers) 41 cases (53.4%). Only 19 patients were diagnosed with COPD, the diagnosis rate of 24.68%. 38 patients without respiratory symptoms (49.35%). Diagnosis of COPD in subjects with GOLD, I grade 23 cases (36.36%), grade LL (40.26%) cases, 15 patients (19.48%), 3 patients with grade IV(3.90%). The survey found that, through the lung function diagnosis of COPD subjects in 49.4%(38/77) without cough, sputum, dyspnea and other symptoms of respiratory system. GOLD class I sub-jects were significantly more than grade II, III, IV subjects (P=0.0002). COPD diagnosis of different GOLD classification rate: I grade L (1/28,3.57%);II in 7 cases (7/33,21.21%);9 patients (9/15, 60%);2 patients with grade IV (2/3, 66.67%). GOLD I grade COPD diagnosis rate was significantly lower than that of grade II, III, IV(P=0.042). Asymptomatic patients with GOLD grade: I grade 23 cases (23/28,82.14%);II in 11 cases (11/33,33.33%);3 patients (9/15,20%). Conclusion The FAWthe prevalence of COPD is higher, but the diagnosis rate is very low, that FAW COPDcommunity prevention and control measures should be further im-proved and perfected.